Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

Clinical trial NCT06288373 · RECRUITING

Trial details

NCT number: NCT06288373
Sponsor: Tongji Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Cervical Cancer Locally Advanced Cervical Cancer Concurrent Chemoradiotherapy Neoadjuvant Chemoimmunotherapy

Start date: 2024-04-22
Primary completion: 2031-03-01
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.